STI 571 (Glivec)

imatinib · Novartis

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for STI 571 (Glivec), covering 2014-02-07 to 2014-02-07. Get the full timeline:

Most recent: Clinical Trial Update: STI 571 (GLIVEC) in the Treatment of Adult Acute Lymphoblastic Leukemia [Phase 2]